Today's Daily Dose brings you news about encouraging interim analysis of Alexion's REGAIN study of Soliris; Fennec's uplisting and preliminary results of SIOPEL 6; Amicus' failed epidermolysis bullosa trial; Vanda's disappointing atopic dermatitis trial results and FDA panel's recommendation for approval of GlaxoSmithKline's investigational shingles vaccine Shingrix.
from RTT - Biotech http://ift.tt/2fk1qE6
via IFTTT
No comments:
Post a Comment